1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
61B1482970009317400258BCE004BAC7E
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/best-practices-improving-medical-affairs-booth-impact-at-critical-medical-congresses?opendocument
18
19opendocument
2018.97.9.168
21
22
23best-in-class.com
24/bestp/domrep.nsf
25BMR




» Products & Services » » Medical Affairs » Medical Communication

Best Practices in Improving Medical Affairs Booth Impact at Critical Medical Congresses

ID: POP-404


Features:

14 Info Graphics

21 Data Graphics

430+ Metrics

11 Narratives


Pages: 44


Published: 2024


Delivery Format: Shipped


 

License Options:


Buy Now

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • STUDY SNAPSHOT
  • KEY FINDINGS
  • VIEW TOC AND LIST OF EXHIBITS
Biopharmas invest heavily in medical booth exhibits to showcase their pipeline and products at key medical conferences and congresses. However, Medical Affairs teams often face challenges in effectively utilizing technology to create compelling and interactive medical information displays, balancing internal compliance requirements with the evolving practices of exhibit booths at major scientific congresses, and measuring the impact of booth investments.

Best Practices, LLC conducted this benchmarking study to provide valuable insights into how biopharma companies can enhance their Medical booth strategies. By analyzing current practices and industry-wide performance levels, this report equips organizations with the knowledge needed to optimize their booth content, display methods, and engagement tactics. It also serves as a comprehensive resource for Medical Affairs teams looking to improve their impact at medical conferences while ensuring compliance and meeting the informational needs of HCPs.

Industries Profiled:
Biotech; Pharmaceutical; Manufacturing; Consumer Products; Diagnostic; Medical Device; Biopharmaceutical; Health Care


Companies Profiled:
Amgen; Astellas; Bayer; Chiesi Global Rare Diseases; EMD Serono; Ipsen; Incyte; Morphic Therapeutic; Novartis; OPEN Health; Protagonist Therapeutics; Purdue Pharma; Regeneron; Takeda Pharmaceuticals; Teva Pharmaceuticals; Vertex Pharmaceuticals; Xenon Pharmaceuticals

Study Snapshot

Best Practices, LLC engaged 20 Medical Communications and Scientific Publications leaders from 17 biopharma companies for this research project. The research employed a quantitative survey as the primary method of data collection, supplemented by qualitative insights to enhance the findings.

Key topics covered in this report include:

  • Medical Affairs Booth Content
  • Display Methods for Medical Booth Content
  • Approaches to US and EU Content
  • Measuring Medical Booth Success
  • Poster/Investigator Events at Congresses
  • Medical Content Utilized by MSLs in the Field

Key Findings

Select key insights uncovered from this report are noted below. Detailed findings are available in the full report.

  • Medical Booth Content and Display: Disease state and pipeline information are shared with congress attendees by a variety of new and traditional means (e.g., static panels, websites, videos, other interactive media). 90-95% of organizations share this information proactively at booths.
Table of Contents

Sr. No.
Topic
Slide No.
I. Executive SummaryPg. 3-8
II. Medical Affairs Booth Content and Information Availability, Display TacticsPg. 9-20
III. Best Practices of Medical Affairs Booth Activities, Performance MeasurementsPg. 21-28
IV. Company-Hosted Poster/Investigator Events at CongressesPg. 29-32
V. Innovative MSL Content Sharing and Participation in Congress EventsPg. 33-39
VI. Benchmark DemographicsPg. 40-43
VII. About Best Practices, LLCPg. 44

    List of Charts & Exhibits

    I. Executive Summary

    • Medical booth impact: Research overview, objectives, methodology, and topics
    • Benchmark study partners
    • Study definitions
    • Key study findings

    II. Medical Affairs Booth Content and Information Availability, Display Tactics

    • Top 5 booth content types shared per display method
    • Types of content shared and displayed at medical booths at congresses
    • Interview narrative around the factors impacting content display at medical information/medical affairs booth
    • Most important factors affecting a biopharma company’s decision for booth content selection
    • Content types and formats available at virtual booths
    • Interview narrative around embracing a mix of technologies to bring attendees to the booth and engage them effectively
    • Most valuable interactive elements for enhancing the learning experience at medical affairs booths
    • Interview narrative around effectiveness of interactive games
    • Differentiation of US, EU, APAC, and other regional information at international congress booths
    • Interview narratives around differentiating medical booth information as per the region

    III. Best Practices of Medical Affairs Booth Activities, Performance Measurements

    • Effective medical booth strategies to pique the attendees’ interest
    • Metrics for evaluating medical booth content impact and effectiveness
    • Comparison of most valuable vs. widely-used metrics for assessing medical information/medical affairs booth content effectiveness
    • Channels used to send posters or other content to congress attendees
    • Permissions for e-mail distribution of posters and content to congress attendees
    • Top practices for medical information/affairs booth content and display at congresses
    • Top pitfalls in medical booth content and display at congresses

    IV. Company-Hosted Poster/Investigator Events at Congresses

    • Hosting poster/investigator receptions at congresses and content utilized
    • Re-use of content from previous congresses at poster receptions and the age of materials used
    • Restrictions on poster/investigator reception attendance at congresses

    V. Innovative MSL Content Sharing and Participation in Congress Events

    • Materials used by MSL teams in the field and sharing methods (proactive vs. reactive)
    • Content availability and sharing methods at congress events
    • Adopting innovative MSL materials
    • Sharing innovative MSL materials
    • MSL utilization of poster books in the field
    • MSL-hosted receptions at medical congresses and attendee eligibility